European Academy of Dermatology and Venereology (EADV) Congress 2025

Twice-daily application of ruxolitinib cream led to early and sustained improvement in the signs and symptoms of prurigo nodularis in adults, according to the pooled phase III TRuE-PN1 and TRuE-PN2 studies presented at EADV 2025.

Patients with psoriasis who are using glucagon-like peptide-1 receptor agonists (GLP-1RAs) appear to have lower risks of mortality and adverse cardiovascular events, according to a retrospective study.

In patients with androgenetic alopecia, 4 months of treatment with the investigational extended-release oral minoxidil (VDPHL01) appears to induce superior hair growth compared with 6 months of treatment with the topical and immediate-release (IR) formulations, according to the results of a blinded retrospective Investigator Global Assessment (IGA) analysis.